Outsourced Pharma App Notes & Case Studies

31. Site Transfer Of Tablet Production From Ex-U.S. To Georgia Site 6/11/2025

    Explore how strategic U.S.-based manufacturing and supply chain diversification can reduce risk, lower costs, and enhance supply reliability for pharmaceutical products.

32. Membrane Adsorber Chromatography In Oligo-mAb Conjugation 8/25/2025

    Discover how the team was able to expedite the conjugation of an oligonucleotide-monoclonal antibody (oligo-mAb) program leveraging experience in chromatography.

33. Boosting Quality And Reducing Complexity With A Single-Provider PV Solution 4/17/2026

    Discover how a German biopharmaceutical company successfully managed growing global pharmacovigilance complexity across more than 2,300 marketing authorizations and a broad partner network.

34. Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology 3/12/2025

    Scale up your manufacturing of adherent cell cultures used for viral vector-based treatments with the novel technologies needed to facilitate safe, rapid production.

35. Particle Removal In Chemical Processing 6/22/2026

    Particles can form or enter during processing, affecting performance. Layered filtration — from early reduction to final polishing — protects operations and improves consistency.

36. Increasing Batch Size And Reducing Cycle Times For A Biologic 8/5/2025

    JHS partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.

37. Customer Story: Emergent BioSolutions Enhances Aseptic Filling Process 1/9/2026

    Upgrading outdated filling systems is essential for meeting future production demands and regulatory standards. Learn how one manufacturer modernized its approach to ensure compliance and efficiency.

38. Facility-Fit-Driven Process Development For A Monoclonal Antibody 11/19/2025

    See how proactively designing around plant constraints, using high-capacity resins, and leveraging parallel workstreams resulted in a 50% reduction in processing hours and 25% lower costs.

39. Develop Clones In Just 9 Weeks From Transfection With Up To 4X Titer 6/15/2026

    Transposon-based cell line development cuts timelines by 10 weeks and hits titers of 4.8 g/L in 17 days. See how SynWeave delivers measurable biologics manufacturing gains.

40. Improving Bioavailability Through Predictive Modeling Of Solubility Enhancement Strategies 7/15/2026

    In silico modeling cut through formulation guesswork for a compound with 0.015 mg/mL solubility, delivering an 8× Cmax and 5× AUC improvement and Phase I progression.